LumiThera is a clinical-stage medical device company focused on use of photobiomodulation ("PBM"), using non-invasive light emitting diodes ("LED") to treat patients with acute and chronic ocular diseases and disorders. Founded by a team of physicians, scientists, and engineers, with backgrounds in the use of photobiomodulation (PBM), using non-invasive light emitting diodes (LED) and laser treatments for acute and chronic ocular diseases and disorders. the Company is currently developing an ophthalmologist LED office-based instrument to be used in treating dry Age-related Macular Degeneration. With a focus on patients with this condition, the device improves vision and slows the loss process. In March 2022 it was announced that LumiThera had acquired Diopsys - a medical devices company offering ERG and VEP vision testing solutions - with the acquired firm ad personnel expected to function as a subsiduary to LumiThera
